Its effects are not unilaterally protumorigenic: mature BDNF/TrkB signaling drives glioma growth, migration, and anti-apoptotic effects, while proBDNF/p75NTR activation inhibits these processes (131). The gene discussed is NGFR; the disease is glioma.